(Q37859322)

24 August 2017

1 reference

title

New paradigms in understanding chronic pelvic pain syndrome (English)

1 reference

24 August 2017

0 references

Katy S Konkle

1

1 reference

24 August 2017

J Quentin Clemens

series ordinal

2

1 reference

24 August 2017

publication date

1 August 2011

1 reference

24 August 2017

published in

Current urology reports

1 reference

24 August 2017

volume

12

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

278-283

1 reference

Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

National prevalence of urogenital pain and prostatitis-like symptoms in Australian men using the National Institutes of Health Chronic Prostatitis Symptoms Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

The prevalence of prostatitis-like symptoms in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Prevalence, symptom impact and predictors of chronic prostatitis-like symptoms in Canadian males aged 16-19 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Relation of Helicobacter pylori infection and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Helicobacter pylori seroprevalence in patients with chronic prostatitis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Uropathogenic Escherichia coli induces chronic pelvic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Prostate secretions from men with chronic pelvic pain syndrome inhibit proinflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Evaluation of a modification of the UPOINT clinical phenotype system for the chronic pelvic pain syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Posterior tibial nerve stimulation in the treatment of urge incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Effectiveness of acupuncture in patients with category IIIB chronic pelvic pain syndrome: a report of 97 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Evidence for overlap between urological and nonurological unexplained clinical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

Comparison of economic impact of chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis/painful bladder syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0185-1

A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS)

21 January 2018

1 reference

12 December 2020

Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment

1 reference

12 December 2020

Prevalence and correlates of prostatitis in the health professionals follow-up study cohort

1 reference

12 December 2020

Sexual dysfunction in type III chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS) observed in Turkish patients

1 reference

12 December 2020

Tenderness as measured by pressure pain thresholds extends beyond the pelvis in chronic pelvic pain syndrome in men.

1 reference

12 December 2020

Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study

1 reference

12 December 2020

Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index

1 reference

12 December 2020

Efficiency of posterior tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain: a Sham-Controlled Comparative Study

1 reference

12 December 2020

Helicobacter pylori seroprevalence in patients with chronic bronchitis

1 reference

12 December 2020

Local anesthetic and steroidal prostatic injection for chronic pelvic pain syndrome: an effective last resort?

1 reference

12 December 2020

Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study

1 reference

12 December 2020

A pilot study of botulinum toxin A for male chronic pelvic pain syndrome

1 reference

12 December 2020

Effects of a 6-month course of tamsulosin for chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized trial.

1 reference

12 December 2020

10.1007/S11934-011-0185-1

Identifiers

DOI

1 reference

24 August 2017

1 reference